Inhibrx Fundamentals

INBX -  USA Stock  

USD 40.09  0.27  0.68%

Inhibrx fundamentals help investors to digest information that contributes to Inhibrx's financial success or failures. It also enables traders to predict the movement of Inhibrx Stock. This fundamental analysis module provides a way for investors to measures Inhibrx's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inhibrx stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Inhibrx Fundamentals 

 
Refresh

Inhibrx Total Debt Analysis

Inhibrx's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Inhibrx Total Debt

36.83 MillionShare
Total Debt 
 = 
Bonds 
+  
Notes 
More About Total Debt | All Equity Analysis

Current Inhibrx Total Debt

    
  37.3 M  
Most of Inhibrx's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inhibrx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Inhibrx Total Debt Historical Pattern

Today, most investors in Inhibrx Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Inhibrx's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Inhibrx total debt as a starting point in their analysis.
 Inhibrx Total Debt 
Share
      Timeline 
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Compare to competition

Inhibrx Total Debt

Total Debt

36.83 MillionShare
Inhibrx Total Debt is fairly stable at the moment as compared to the past year. Inhibrx reported Total Debt of 37.45 Million in 2020
Based on the latest financial disclosure, Inhibrx has a Total Debt of 37.3 M. This is 98.64% lower than that of the Healthcare sector and 88.52% lower than that of the Biotechnology industry. The total debt for all United States stocks is 99.3% higher than that of the company.

Inhibrx Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Inhibrx's current stock value. Our valuation model uses many indicators to compare Inhibrx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inhibrx competition to find correlations between indicators driving Inhibrx's intrinsic value. More Info.
Inhibrx is currently regarded as number one stock in debt to equity category among related companies. It is rated second overall in operating margin category among related companies .

Inhibrx Institutional Holders

Institutional Holdings refers to the ownership stake in Inhibrx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Inhibrx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Inhibrx's value.
Security TypeSharesValue
Viking Global Investors LpCommon Shares5.3 M146 M
Wellington Management Group LlpCommon Shares2.1 M59.1 M
Blackrock IncCommon Shares1.5 M41.2 M
Fmr LlcCommon Shares1.5 M40.2 M
Arrowmark Colorado Holdings LlcCommon Shares1.4 M39.8 M
Capital World InvestorsCommon Shares1.2 M33 M
Tybourne Capital Management Hk LtdCommon Shares1.1 M30.3 M

Inhibrx Fundamentals

About Inhibrx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Inhibrx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inhibrx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inhibrx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2021
Deferred Revenue3.8 M4.7 M
Revenues12.9 M13.5 M
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. Inhibrx, Inc. was founded in 2010 and is headquartered in La Jolla, California. Inhibrx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 84 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Inhibrx without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Inhibrx using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Inhibrx Piotroski F Score and Inhibrx Altman Z Score analysis. Note that the Inhibrx information on this page should be used as a complementary analysis to other Inhibrx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Inhibrx Stock analysis

When running Inhibrx price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
The market value of Inhibrx is measured differently than its book value, which is the value of Inhibrx that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibrx's value that differs from its market value or its book value, called intrinsic value, which is Inhibrx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibrx's market value can be influenced by many factors that don't directly affect Inhibrx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibrx's value and its price as these two are different measures arrived at by different means. Investors typically determine Inhibrx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibrx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.